Figure 12: A, B, C, D as it displays the biodistribution of indium-111-labelled PEGylated liposomes. These images were taken 72 hours after injection by SPECT imaging. A shows the overall biodistribution of the nanocarriers, which was targeted at the tumour located in the tongue (Tu). The other places revealed that the nanocarrier collected was in the image was the patient’s cardiac pool (CP), liver (L) and Spleen (Spl). B, C, D shows a detailed image of the distribution of Indium-111-labelled PEGylated liposomes in a tumour in the tongue. Image adapted from Reference [37].